Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Nov 17 2023

Full Issue

Measles Cases And Deaths Jump Worldwide By Alarming Rates, WHO Says

Measles cases rose 18% last year, and deaths increased by 40%, according to a new World Health Organization report. And the trend can be expected to continue as child vaccination rates are decreasing, in what could lead to a public health "disaster" for vulnerable kids.

Reuters: 'Staggering' Rise In Measles Cases Last Year, Says WHO And CDC 

There was a “staggering” annual rise in measles cases and deaths in 2022, according to a new report from the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC). Cases jumped by 18% to an estimated 9 million, and deaths to 136,000, mostly among children, the health agencies said in a joint statement on Thursday. There were large or disruptive outbreaks in 37 countries last year, the majority in Africa, compared to 22 in 2021. (Rigby, 11/16)

Stat: Measles Cases And Deaths Increase Worldwide, Report Finds

The problem is mounting, with year-to-date numbers for 2023 on track to potentially double the 2022 figures, Natasha Crowcroft, the WHO’s global lead for measles and rubella, told STAT in an interview. “If this carries on the direction it’s going in, this is going to be a disaster for children in the most vulnerable settings,” Crowcroft said. (Branswell, 11/16)

AP: Measles Deaths Worldwide Jumped 40% Last Year, Health Agencies Say 

Measles is among the most infectious diseases known and spreads in the air when an infected person coughs or sneezes. It is most common in children under 5. Symptoms include fever, cough, runny nose and a distinctive rash. Most deaths are due to complications like encephalitis, severe dehydration, serious breathing problems and pneumonia. Complications are most likely in young children and adults over 30.The disease has also surged in some rich countries in recent years. British health authorities warned in July that there was an extremely high risk of outbreaks in London, with some areas of the capital reporting that only 40% of children were vaccinated. (11/16)

CIDRAP: WHO And CDC Warn Of Rising Measles Cases And Deaths

The researchers also saw coverage gaps of the vaccine, which is given as a two-dose series. Though global vaccine coverage was up modestly between 2021 and 2022, 33 million kids missed a measles vaccine dose, including 22 million who didn't get their first dose and 11 million who never received their second shot. (Schnirring, 11/16)

On the global spread of tuberculosis —

NPR: Can TB Be Eliminated? This Year Brings Progress But Obstacles Loom

A promising way to prevent the spread of drug-resistant tuberculosis was announced at the Union World Conference on Lung Health on Thursday in Paris. Two clinical trials, conducted in South Africa and Vietnam, looked at levofloxacin, one of the antibiotics most commonly used to treat people who've developed drug-resistant TB. Now there's strong evidence that taking the drug can reduce the risk of developing drug-resistant strains of the bacterial disease by about 60%. (Kritz, 11/16)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF